Cardiovascular and venous thromboembolic events in systemic sclerosis: epidemiological analysis of the Clinical

John D Pauling1,2,3, Rachel Charlton2, Laura Ross4,5

  • 1Department of Rheumatology, North Bristol NHS Trust, Bristol, UK.

PubMed

Insights

Systemic sclerosis (SSc) patients face increased risks of cardiovascular events and venous thromboembolism (VTE), both before and after diagnosis. Further research is needed to understand these thrombotic events and improve patient outcomes.

Area of Science:

  • Rheumatology
  • Cardiology
  • Epidemiology

Background:

  • Cardiovascular disease (CVD) is a primary cause of mortality in systemic sclerosis (SSc).
  • Understanding the association between SSc and cardiovascular/thromboembolic events is crucial for patient management.

Purpose of the Study:

  • To investigate the association between systemic sclerosis (SSc) and the occurrence of cardiovascular and thromboembolic events.
  • To analyze event rates in SSc patients compared to matched non-SSc individuals.

Main Methods:

  • A cohort study utilized the Clinical Practice Research Datalink (CPRD) to identify SSc cases.
  • Rates of coronary arterial disease (CAD), cerebrovascular disease, peripheral artery disease (PAD), and venous thromboembolism (VTE) were compared between SSc patients and matched controls.
  • Cox regression analysis adjusted for traditional cardiovascular risk factors.

Main Results:

  • A higher prevalence of CAD, PAD, and VTE was observed at baseline in the SSc cohort.
  • SSc patients exhibited a significantly increased risk of CAD, PAD, peripheral venous thromboses, and pulmonary embolism during follow-up (adjusted hazard ratios 1.84-3.01).
  • No increased risk of cerebrovascular disease was found in SSc patients.

Conclusions:

  • Systemic sclerosis is associated with an elevated risk of cardiovascular events and VTE, occurring both before and within 8 years of diagnosis.
  • Further research is required to elucidate the mechanisms underlying arterial and venous thrombotic events in SSc.
  • Identifying these mechanisms can lead to more targeted preventative strategies and improved outcomes for SSc patients.
Abstract

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
294
Varicose Veins II: Diagnostic Studies and Interprofessional Care01:26

Varicose Veins II: Diagnostic Studies and Interprofessional Care

Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
192
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
501
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
280
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
202
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
379